0001562180-23-006222.txt : 20230807
0001562180-23-006222.hdr.sgml : 20230807
20230807160713
ACCESSION NUMBER: 0001562180-23-006222
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230803
FILED AS OF DATE: 20230807
DATE AS OF CHANGE: 20230807
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Leschly Nick
CENTRAL INDEX KEY: 0001578408
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40791
FILM NUMBER: 231147642
MAIL ADDRESS:
STREET 1: C/O BLUEBIRD BIO, INC.
STREET 2: 840 MEMORIAL DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: 2seventy bio, Inc.
CENTRAL INDEX KEY: 0001860782
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 863658454
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
BUSINESS PHONE: 339-499-9300
MAIL ADDRESS:
STREET 1: 60 BINNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02210
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0508
4
2023-08-03
false
0001860782
2seventy bio, Inc.
TSVT
0001578408
Leschly Nick
60 BINNEY STREET
CAMBRIDGE
MA
02142
true
true
false
false
President and CEO
true
Common Stock
2023-08-03
4
S
false
9060.00
6.1257
D
1168654.00
D
Common Stock
15233.00
I
Nick Leschly 2001 Trust
Common Stock
41000.00
I
Nick Leschly Irrevocable GST Trust of 2019
Shares were sold to cover tax withholding obligations incurred in connection with the vesting of restricted stock units.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.06 to $6.23, inclusive. The Reporting Person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The Form 4 filed on July 19, 2022 inadvertently understated the Reporting Person's holdings by 133,500 shares, an error that was carried forward on subsequent filings. Column 5 of Table I reflects the number of shares of Issuer common stock beneficially owned by the Reporting Person following the reported transactions as of August 7, 2023.
/s/ Teresa Jurgensen, Attorney-in-Fact
2023-08-07